These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
654 related items for PubMed ID: 31645661
1. A novel compound AB38b attenuates oxidative stress and ECM protein accumulation in kidneys of diabetic mice through modulation of Keap1/Nrf2 signaling. Du L, Wang L, Wang B, Wang J, Hao M, Chen YB, Li XZ, Li Y, Jiang YF, Li CC, Yang H, Gu XK, Yin XX, Lu Q. Acta Pharmacol Sin; 2020 Mar; 41(3):358-372. PubMed ID: 31645661 [Abstract] [Full Text] [Related]
2. CKIP-1 affects the polyubiquitination of Nrf2 and Keap1 via mediating Smurf1 to resist HG-induced renal fibrosis in GMCs and diabetic mice kidneys. Gong W, Chen Z, Zou Y, Zhang L, Huang J, Liu P, Huang H. Free Radic Biol Med; 2018 Feb 01; 115():338-350. PubMed ID: 29248720 [Abstract] [Full Text] [Related]
5. Astaxanthin Promotes Nrf2/ARE Signaling to Inhibit HG-Induced Renal Fibrosis in GMCs. Xie X, Chen Q, Tao J. Mar Drugs; 2018 Apr 05; 16(4):. PubMed ID: 29621130 [Abstract] [Full Text] [Related]
6. Sirt1 resists advanced glycation end products-induced expressions of fibronectin and TGF-β1 by activating the Nrf2/ARE pathway in glomerular mesangial cells. Huang K, Huang J, Xie X, Wang S, Chen C, Shen X, Liu P, Huang H. Free Radic Biol Med; 2013 Dec 05; 65():528-540. PubMed ID: 23891678 [Abstract] [Full Text] [Related]
7. Bergenin impedes the generation of extracellular matrix in glomerular mesangial cells and ameliorates diabetic nephropathy in mice by inhibiting oxidative stress via the mTOR/β-TrcP/Nrf2 pathway. Qiao S, Liu R, Lv C, Miao Y, Yue M, Tao Y, Wei Z, Xia Y, Dai Y. Free Radic Biol Med; 2019 Dec 05; 145():118-135. PubMed ID: 31494242 [Abstract] [Full Text] [Related]
8. Novel Chalcone BDD-39 Mitigated Diabetic Nephropathy through the Activation of Nrf2/ARE Signaling. Adelusi T, Li X, Xu L, Du L, Hao M, Zhou X, Chowdhry A, Sun Y, Gu X, Lu Q, Yin X. Curr Mol Pharmacol; 2022 Dec 05; 15(4):658-675. PubMed ID: 34525927 [Abstract] [Full Text] [Related]
10. SP600125 suppresses Keap1 expression and results in NRF2-mediated prevention of diabetic nephropathy. Zhang H, Liu X, Zhou S, Jia Y, Li Y, Song Y, Wang J, Wu H. J Mol Endocrinol; 2018 Feb 05; 60(2):145-157. PubMed ID: 29273684 [Abstract] [Full Text] [Related]
11. Discovery of caffeoylisocitric acid as a Keap1-dependent Nrf2 activator and its effects in mesangial cells under high glucose. Yao H, Zhang W, Yang F, Ai F, Du D, Li Y. J Enzyme Inhib Med Chem; 2022 Dec 05; 37(1):178-188. PubMed ID: 34894983 [Abstract] [Full Text] [Related]
12. Salvia miltiorrhiza Lipophilic Fraction Attenuates Oxidative Stress in Diabetic Nephropathy through Activation of Nuclear Factor Erythroid 2-Related Factor 2. An L, Zhou M, Marikar FMMT, Hu XW, Miao QY, Li P, Chen J. Am J Chin Med; 2017 Dec 05; 45(7):1441-1457. PubMed ID: 28946766 [Abstract] [Full Text] [Related]
13. Polydatin promotes Nrf2-ARE anti-oxidative pathway through activating CKIP-1 to resist HG-induced up-regulation of FN and ICAM-1 in GMCs and diabetic mice kidneys. Gong W, Li J, Chen Z, Huang J, Chen Q, Cai W, Liu P, Huang H. Free Radic Biol Med; 2017 May 05; 106():393-405. PubMed ID: 28286065 [Abstract] [Full Text] [Related]
14. Diphenyl diselenide alleviates diabetic peripheral neuropathy in rats with streptozotocin-induced diabetes by modulating oxidative stress. Wang X, Huan Y, Li C, Cao H, Sun S, Lei L, Liu Q, Liu S, Ji W, Liu H, Huang K, Zhou J, Shen Z. Biochem Pharmacol; 2020 Dec 05; 182():114221. PubMed ID: 32949583 [Abstract] [Full Text] [Related]
15. BML-111 attenuates high glucose-induced inflammation, oxidative stress and reduces extracellular matrix accumulation via targeting Nrf2 in rat glomerular mesangial cells. Wu X, Pan C, Chen R, Zhang S, Zhai Y, Guo H. Int Immunopharmacol; 2020 Feb 05; 79():106108. PubMed ID: 31881376 [Abstract] [Full Text] [Related]
16. Phenethyl isothiocyanate attenuates diabetic nephropathy via modulation of glycative/oxidative/inflammatory signaling in diabetic rats. Eisa NH, Khodir AE, El-Sherbiny M, Elsherbiny NM, Said E. Biomed Pharmacother; 2021 Oct 05; 142():111666. PubMed ID: 34215478 [Abstract] [Full Text] [Related]
19. Keap1/Nrf2/ARE signaling unfolds therapeutic targets for redox imbalanced-mediated diseases and diabetic nephropathy. Adelusi TI, Du L, Hao M, Zhou X, Xuan Q, Apu C, Sun Y, Lu Q, Yin X. Biomed Pharmacother; 2020 Mar 05; 123():109732. PubMed ID: 31945695 [Abstract] [Full Text] [Related]
20. Targeting the KEAP1-NRF2 System to Prevent Kidney Disease Progression. Nezu M, Suzuki N, Yamamoto M. Am J Nephrol; 2017 Mar 05; 45(6):473-483. PubMed ID: 28502971 [Abstract] [Full Text] [Related] Page: [Next] [New Search]